YONIE LEBLANC: Open Payments
NPI 1407240856 · WOODSTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 18 payments from 12 companies in 2025. Trend: 2023 $252 · 2024 $441 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| SHIELD THERAPEUTICS INC | 2 | $45 |
| Exact Sciences Corporation | 1 | $34 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: FARXIGA, ACCRUFER, AIRSUPRA, Cologuard Collection Kit, TZIELD, UBRELVY, MOUNJARO, BREZTRI.
Industry payments across NJ — which companies pay providers there.
